IPILIMUMAB, AXITINIB, PF-08634404, AXITINIB
C6461008
Phase 2 small_molecule active
Quick answer
IPILIMUMAB, AXITINIB, PF-08634404, AXITINIB for ADVANCED OR METASTATIC RENAL CELL CARCINOMA is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- ADVANCED OR METASTATIC RENAL CELL CARCINOMA
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active